GHRS GH Research PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: GHRS

Price (delayed)

$11.68

Market cap

$607.69M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$531.1M

gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.

Highlights
GH Research's debt has decreased by 20% YoY and by 8% QoQ
GH Research's net income has decreased by 17% YoY but it has increased by 9% from the previous quarter
GHRS's EPS is down by 17% year-on-year but it is up by 9% since the previous quarter
GH Research's equity has decreased by 13% YoY and by 4.2% QoQ
The quick ratio fell by 12% YoY and by 10% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of GHRS
Market
Shares outstanding
52.03M
Market cap
$607.69M
Enterprise value
$531.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.9
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$31.59M
EBITDA
-$31.27M
Free cash flow
-$40.36M
Per share
EPS
-$0.62
Free cash flow per share
-$0.78
Book value per share
$4.03
Revenue per share
$0
TBVPS
$4.18
Balance sheet
Total assets
$217.58M
Total liabilities
$7.84M
Debt
$897,000
Equity
$209.75M
Working capital
$153.2M
Liquidity
Debt to equity
0
Current ratio
22.06
Quick ratio
21.7
Net debt/EBITDA
2.45
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-14.1%
Return on equity
-14.6%
Return on invested capital
-22.8%
Return on capital employed
-15%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GHRS stock price

How has the GH Research stock price performed over time
Intraday
4.38%
1 week
11.13%
1 month
6.28%
1 year
37.41%
YTD
101.38%
QTD
9.57%

Financial performance

How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$42.33M
Net income
-$32.32M
Gross margin
N/A
Net margin
N/A
GH Research's operating income has decreased by 28% YoY and by 2.7% from the previous quarter
GH Research's net income has decreased by 17% YoY but it has increased by 9% from the previous quarter

Growth

What is GH Research's growth rate over time

Valuation

What is GH Research stock price valuation
P/E
N/A
P/B
2.9
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 17% year-on-year but it is up by 9% since the previous quarter
The price to book (P/B) is 32% more than the last 4 quarters average of 2.2
GH Research's equity has decreased by 13% YoY and by 4.2% QoQ

Efficiency

How efficient is GH Research business performance
GHRS's return on invested capital has surged by 54% year-on-year and by 8% since the previous quarter
GHRS's return on equity is down by 34% year-on-year but it is up by 6% since the previous quarter
The return on assets has declined by 32% year-on-year but it is up by 6% since the previous quarter

Dividends

What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GHRS.

Financial health

How did GH Research financials performed over time
GH Research's total assets has decreased by 13% YoY and by 3.9% from the previous quarter
The quick ratio fell by 12% YoY and by 10% QoQ
GH Research's debt is 100% lower than its equity
GH Research's debt has decreased by 20% YoY and by 8% QoQ
GH Research's equity has decreased by 13% YoY and by 4.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.